the monoclonal antibody , orthoclone okt3 ( okt3 ) , has been used with great efficacy in a prospective multicenter trial as therapy for first rejection episodes in cadaveric donor ( cd ) renal allograft recipients treated with azathioprine ( aza ) and prednisone ( p ) .
C0733466
orthoclone okt3
C0085379
okt3